Indalecio Carboni Bisso1, Melina Garbarini2, Carolina Lockhart3, Sonia Villarroel4, José Chas5, Vadim Kotowicz6, Eduardo San Román7, Marcos Las Heras8. 1. Terapia Intensiva de Adultos, Hospital Italiano de Buenos Aires. indalecio.carbonibisso@hospitalitaliano.org.ar. 2. Terapia Intensiva de Adultos, Hospital Italiano de Buenos Aires. melina.garbarini@hospitalitaliano.org.ar. 3. Terapia Intensiva de Adultos, Hospital Italiano de Buenos Aires. carolina.lockhart@hospitalitaliano.org.ar. 4. Terapia Intensiva de Adultos, Hospital Italiano de Buenos Aires. sonia.villarroel@hospitalitaliano.org.ar. 5. Cirugía Cardiovascular, Hospital Italiano de Buenos Aires. jose.chas@hospitalitaliano.org.ar. 6. Cirugía Cardiovascular, Hospital Italiano de Buenos Aires. vadim.kotowicz@hospitalitaliano.org.ar. 7. Terapia Intensiva de Adultos, Hospital Italiano de Buenos Aires. eduardo.sanroman@hospitalitaliano.org.ar. 8. Terapia Intensiva de Adultos, Hospital Italiano de Buenos Aires. marcos.lasheras@hospitalitaliano.org.ar.
Abstract
Introduction: The role of the use of Extracorporeal Membrane Oxygenation (ECMO) in patients with coronavirus disease (COVID-19) is under discussion. Whereas in patients with Acute Respiratory Distress Syndrome (ARDS) the ECMO is a usual rescue measure used to optimize the oxygenation as a bridge to pulmonary rehabilitation, in patients that have refractory hypoxemic respiratory failure with recovery potential, the use of ECMO could also be beneficial. Objective: The purpose of this work is to report the first case of COVID-19 that required ECMO in Argentina, with a good response. Methodology: We describe the first case of COVID-19 that required ECMO in Argentina, in a patient without comorbidities, with good clinical results. Results: The use of ECMO in the reported case provided a substantial benefit in oxygenation, acting as a bridge to lung recovery, without presenting complications associated with its application. Conclusion: In critically ill patients with refractory hypoxemia, but with high recovery potential, ECMO support can be considered as a rescue measure. Universidad Nacional de Córdoba.
Introduction: The role of the use of Extracorporeal Membrane Oxygenation (ECMO) in patients with coronavirus disease (COVID-19) is under discussion. Whereas in patients with Acute Respiratory Distress Syndrome (ARDS) the ECMO is a usual rescue measure used to optimize the oxygenation as a bridge to pulmonary rehabilitation, in patients that have refractory hypoxemic respiratory failure with recovery potential, the use of ECMO could also be beneficial. Objective: The purpose of this work is to report the first case of COVID-19 that required ECMO in Argentina, with a good response. Methodology: We describe the first case of COVID-19 that required ECMO in Argentina, in a patient without comorbidities, with good clinical results. Results: The use of ECMO in the reported case provided a substantial benefit in oxygenation, acting as a bridge to lung recovery, without presenting complications associated with its application. Conclusion: In critically ill patients with refractory hypoxemia, but with high recovery potential, ECMO support can be considered as a rescue measure. Universidad Nacional de Córdoba.
Authors: Alain Combes; David Hajage; Gilles Capellier; Alexandre Demoule; Sylvain Lavoué; Christophe Guervilly; Daniel Da Silva; Lara Zafrani; Patrice Tirot; Benoit Veber; Eric Maury; Bruno Levy; Yves Cohen; Christian Richard; Pierre Kalfon; Lila Bouadma; Hossein Mehdaoui; Gaëtan Beduneau; Guillaume Lebreton; Laurent Brochard; Niall D Ferguson; Eddy Fan; Arthur S Slutsky; Daniel Brodie; Alain Mercat Journal: N Engl J Med Date: 2018-05-24 Impact factor: 91.245
Authors: Liam J Donaldson; Paul D Rutter; Benjamin M Ellis; Felix E C Greaves; Oliver T Mytton; Richard G Pebody; Iain E Yardley Journal: BMJ Date: 2009-12-10